Suppr超能文献

依诺卡因乳膏引起的接触性荨麻疹。

Contact urticaria from Emla cream.

作者信息

Waton J, Boulanger A, Trechot P H, Schmutz J L, Barbaud A

机构信息

Dermatology Department, Fournier Hospital, Nancy, France.

出版信息

Contact Dermatitis. 2004 Nov-Dec;51(5-6):284-7. doi: 10.1111/j.0105-1873.2004.00475.x.

Abstract

We report the first case of immediate-type hypersensitivity caused by Emla cream. A 55-year-old woman, after using Emla cream, went on to develop urticaria. An open test was positive to Emla cream. Patch tests and prick tests were performed with Emla cream, the components of Emla cream (lidocaine, prilocaine and castor oil) and other local anaesthetics. The patch test with lidocaine and the prick test with Emla cream were both positive. An intradermal test and subcutaneous administration of 3 anaesthetics that had negative patch tests and prick tests were performed and well tolerated, allowing their use. In the literature, anaphylactic reactions to lidocaine injections, delayed-type hypersensitivity after lidocaine subcutaneous injections and contact dermatitis from Emla cream have all been described. This first case of contact urticaria from Emla cream was due to lidocaine and did not show any cross-reaction with other local anaesthetics.

摘要

我们报告了首例由复方利多卡因乳膏引起的速发型超敏反应病例。一名55岁女性在使用复方利多卡因乳膏后出现了荨麻疹。开放性试验显示对复方利多卡因乳膏呈阳性反应。对复方利多卡因乳膏、其成分(利多卡因、丙胺卡因和蓖麻油)以及其他局部麻醉剂进行了斑贴试验和点刺试验。利多卡因斑贴试验和复方利多卡因乳膏点刺试验均呈阳性。对斑贴试验和点刺试验呈阴性的3种麻醉剂进行了皮内试验和皮下注射,患者耐受性良好,可使用这些麻醉剂。文献中已描述了利多卡因注射引起的过敏反应、利多卡因皮下注射后的迟发型超敏反应以及复方利多卡因乳膏引起的接触性皮炎。这首例复方利多卡因乳膏引起的接触性荨麻疹病例是由利多卡因导致的,且未显示出与其他局部麻醉剂有任何交叉反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验